“The Amissa platform successfully enables digital biomarker development and helps to address disparities in clinical trials and research studies of underrepresented groups through decentralized data collection.”
The smartest way tocollect research data.
Thesmartestwaytocollect research dataprovide personalized careunderstand women’s healthcollect research data.
collect research data
provide personalized care
understand women’s health
We transform complex wearable data into actionable insights for researchers, clinicians and patients to better understand human health and improve care delivery.
What We Do
Harness Wearable Data for Smarter Research and Patient Care
Amissa empowers healthcare providers and researchers to easily collect, analyze, and act on Apple Watch data from both patients and study participants. No more data overload—just the key insights you need to drive better outcomes and groundbreaking discoveries.
Amissa empowers healthcare providers and researchers to easily collect, analyze, and act on Apple Watch data from both patients and study participants. No more data overload—just the key insights you need to drive better outcomes and groundbreaking discoveries.
Effortless Enrollment
Quickly add patients or study participants to the Amissa platform and assign them to a tailored clinical or research pathway.Seamless Data Collection
Participants connect their Apple Watch to the Amissa app, automatically tracking vitals, menopause-related symptoms, and other health metrics.Clear, Actionable Insights
Receive high-quality biometric and symptom feedback, with key trends and outliers highlighted—ensuring you focus on what matters most.Collaborative, Data-Driven Decision Making
Providers, researchers, and participants work from the same real-time data, making it easier to refine treatments, adjust research protocols, and improve health outcomesTrusted by Leading Organizations
Areas of Focus
Menopause
On average, perimenopause lasts four years, but can continue for up to eight years until women finally reach menopause. Approximately 1.3 million U.S. women become menopausal each year. Yet, research in this area has been underfunded — leading to significant lack of understanding of symptoms and effective treatments. Women are anxious for guidance and solutions as they go through that phase of life. Amissa is partnering with patients and providers to develop next generation digital biomarkers to close the gaps in our understanding of perimenopause and improve individualized treatment.
Alzheimer’s
An estimated 6.7 million Americans over 65 are living with Alzheimer’s disease, and almost two-thirds of these are women. Researchers are now finding connections between hormonal changes and lifestyle interruptions that occur during menopause and may link to a dementia diagnosis. Amissa has developed machine learning models that predict preclinical Alzheimer’s disease based upon Apple Watch data. We continue to partner with leading research institutions to understand dementia and cognitive decline.
News & Updates
“The high-frequency patient-generated health and behavior data collected by the Amissa Health application on Apple Watches, such as heart rate, activity levels, sleep patterns, and other physiological parameters, can contain subtle patterns that could be indicative of cognitive decline associated with dementia.”
“With this funding from the NIA, Amissa Health will initiate longitudinal health measurements and test the feasibility of collecting and centralizing health information to advance equitable population health science.”